Platelet function testing as a biomarker for efficacy of antiplatelet drugs.


Despite the overwhelming evidence in support of the efficacy of dual antiplatelet therapy with aspirin and clopidogrel, it is also obvious that not all patients benefit from these drugs to the same extent. This interindividual variability in platelet responses may underlie clinical differences in drug efficacy, with potential for optimization of… (More)
DOI: 10.2217/bmm-2016-0070


  • Presentations referencing similar topics